Metraipolis › archive › dc_f252ca161a1d
Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy — Europe PMC PMID:41638771
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41638771
- DOI
- 10.1002/jcsm.70200
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:59:43.823Z
- SHA-256 of the archived text
0b59e5c36887c7b9363d64b271e26222ec415e4264f1d5cc8bfe39f9f66abd42- Stable URL of this page
https://metraipolis.com/documento/dc_f252ca161a1d
How to cite
Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy — Europe PMC PMID:41638771 — Europe PMC (en), https://europepmc.org/article/MED/41638771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f252ca161a1d (Metraipolis archive dc_f252ca161a1d, sha256 0b59e5c36887c7b9363d64b271e26222ec415e4264f1d5cc8bfe39f9f66abd42)
BibTeX
@misc{dcf252ca161a1d,
title = {Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy — Europe PMC PMID:41638771},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41638771},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f252ca161a1d; sha256 0b59e5c36887c7b9363d64b271e26222ec415e4264f1d5cc8bfe39f9f66abd42},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41638771. Agents can read the archived copy with the MCP tool read_document.